ARCHIVES

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

Cancer Advocacy: Jay Hedlund Resigns As NPCC President

May 14, 1999

Research Funding: Clinton Proposes 2.6% Increase For NIH, Amount Called “Paltry”

February 14, 1997

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991

Clinton Declares Month of April Cancer Control Month

April 11, 1997